Clinical trials
Recruiting Observational Connective Tissue Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Bonn | 2 |
| American Thrombosis and Hemostasis Network | 1 |
| Azienda Unita Sanitaria Locale di Piacenza | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| EPIMAR registry | 1 |
| Hospital for Special Surgery, New York | 1 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 1 |
| Medical University Innsbruck | 1 |
| Qilu Hospital of Shandong University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Connective Tissue Diseases | 15 |
| Lung Diseases, Interstitial | 7 |
| Arthritis, Rheumatoid | 5 |
| Idiopathic Pulmonary Fibrosis | 4 |
| Scleroderma, Systemic | 3 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2 |
| Arthritis, Psoriatic | 2 |
| Giant Cell Arteritis | 2 |
| Myositis | 2 |
| Polymyalgia Rheumatica | 2 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.